Sino Biopharm unit licenses blood cancer drug to Sanofi for up to $1.53 bln - Reuters

Reuters | March 3, 2026, 6:13 p.m. | Original
Sino Biopharm unit licenses blood cancer drug to Sanofi for up to $1.53 bln Reuters
CrowdStrike forecasts fiscal 2027 revenue above estimates on cybersecurity tools demand - Reuters Pentagon identifies first US soldiers killed in Iran war - Reuters